Major Pharmaceuticals recalls Levothyroxine Sodium Tablets, USP, 125 mcg (0.0125 mg), 100 Tablets (10 x 10 unit dose blisters) per carton, Rx only, Pa
Recalled July 29, 2026 · FDA recall D-0705-2026 · Major Pharmaceuticals
Hazard
Subpotent Drug · FDA Class II
Units
N/A
Sold at
Nationwide in the USA.
Description
Subpotent Drug
Product
Levothyroxine Sodium Tablets, USP, 125 mcg (0.0125 mg), 100 Tablets (10 x 10 unit dose blisters) per carton, Rx only, Packaged and Distributed by: MAJOR PHARMACEUTICALS, Indianapolis, IN 46268 USA. NDC: 0904-6955-61
Manufacturer(s)
Major Pharmaceuticals
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →